Activity of melflufen in RR MM patients with extramedullary disease in the phase 2 HORIZON study (OP-106): Promising results in a high-risk population Meeting Abstract
| Authors: | Richardson, P. G.; Mateos, M. V.; Rodriguez-Otero, P.; Norkin, M.; Larocca, A.; Hassoun, H.; Alegre, A.; Paner, A.; Leleu, X.; Maisel, C.; Mazumder, A.; Harmenberg, J.; Byrne, C.; Zubair, H.; Thuresson, S.; Blade, J. |
| Abstract Title: | Activity of melflufen in RR MM patients with extramedullary disease in the phase 2 HORIZON study (OP-106): Promising results in a high-risk population |
| Meeting Title: | 17th International Myeloma Workshop |
| Journal Title: | Clinical Lymphoma, Myeloma and Leukemia |
| Volume: | 19 |
| Issue: | 10 Suppl. |
| Meeting Dates: | 2019 Sep 12-15 |
| Meeting Location: | Boston, MA |
| ISSN: | 2152-2650 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2019-10-01 |
| Start Page: | e352 |
| End Page: | e353 |
| Language: | English |
| ACCESSION: | WOS:000491229800577 |
| DOI: | 10.1016/j.clml.2019.09.582 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: OAB-86 -- Source: Wos |
